Back
ESC Premium Access

Change in CHA2DS2-VASc score (delta CHA2DS2-VASc score) and the risk of thromboembolism over 12-years follow-up in initially low-risk patients with first-diagnosed atrial fibrillation

Session: Poster Session 3 - Atrial fibrillation - Stroke prevention
Topic: Clinical
Speaker: Associate Professor T. Potpara (Belgrade, RS)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Tatjana Potpara

School of Medicine, Belgrade University, Belgrade (Serbia)
44 presentations
3 followers

10 more presentations in this session

Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients: a dose subgroup analysis of the ARISTOPHANES study

Speaker: Doctor X. Li (Princeton, US)

Access
Abstract
Slides
Like
Thumbnail

Age threshold for ischemic stroke risk in atrial fibrillation: cohort data covering the entire Korean population

Speaker: Assistant Professor H. Yu (Seoul, KR)

Access
Abstract
Like
Thumbnail

Antiplatelet therapy use in atrial fibrillation patients taking oral anticoagulation: an analysis of adverse outcomes from the FANTASIIA registry.

Speaker: Doctor M. Esteve Pastor (Murcia, ES)

Access
Abstract
Like
Thumbnail

Evaluation of appropriate use and clinical outcomes of idarucizumab as antidote of dabigatran in daily clinical practice

Speaker: Mr S. van der Wall (Haarlem, NL)

Access
Abstract
Slides
Like
Thumbnail

The new warfarin dosing algorithm for patients with atrial fibrillation and severe chronic kidney disease

Speaker: Doctor Z. Salpagarova (Moscow, RU)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 3 - Atrial fibrillation - Stroke prevention

Speakers: Associate Professor T. Potpara, Doctor X. Li, Assistant Professor H. Yu, Doctor M. Esteve Pastor, Mr S. van der Wall...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources